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sampling  and  measurement  will  allow  progress  in
development of methods to minimise personal expo-
sure to aeroallergen.
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Endotoxin  and  its  purified  derivative  lipopolysac-
charide (LPS) are Gram-negative bacterial potent pro-
inflammatory  constituents  continuously  shed  into
the  environment.1 A  number  of  different  Gram-
negative bacteria inhabits the normal body surfaces
including  the  skin,  oral  cavity,  respiratory  tract,
gastrointestinal  tract,  vagina  and  urinary  tract.
Humans  can  be  exposed  to  endotoxin  via  several
ways.  In  addition  to  the  septic  shock  frequentlycaused  by  translocation  of  Gram-negative  micro-
organisms normally present in the gut of the host to
the  circulation,  there  is  continuous  exposure  to
airborne endotoxin. The release of  endotoxin from
Gram-negative bacteria that colonise the respiratory
tract in the majority of patients with chronic bron-
chitis can contribute to the lung  function decrease
by initiating release of inflammatory mediators from
bronchial  epithelial  cells.2 High  levels  of  airborne
(up to 1mg/m3) endotoxin have been reported from
a  variety  of  occupational environments (e.g.  swine
confinement,  poultry  farm,  cotton  mill,  brewery,
waste  processing).1 A  number  of  cross-sectional
studies reports an association between exposure to
endotoxin measured in the dust from those occupa-
tional  settings  and  the  risk  to  develop  non-atopic
chronic  obstructive  pulmonary  diseases,3–6 toxic
pneumonitis and systemic effects.7,8 In the domestic
environment, there is also endotoxin contaminating
house dust9–12 that, by itself or in association with
allergen  exposure,  could  be  an  important  determi-
nant  of  asthma  severity.9,10 Recently,  Hasday  et  al.
reported that high levels of endotoxin are produced
by cigarette smoke.13
Inhalation of pure  endotoxin may elicit, in  some
individuals, dyspnea, chest tightness, myalgia, shivers,
fatigue and malaise associated or not with fever.14,15A
similar clinical response is observed after exposure to
dust containing endotoxin such as grain handlers,16
cotton  workers,5 fibre-glass  manufacturing  employ-
ees,8 or  animal  farmers.17 A  large  inter-individual
variability  in  the  sensitivity  to  endotoxin has  been
reported.18–20 In  humans,  inhalation of  pure  endo-
toxin  is  associated  with  bronchoconstric-
tion,14,15,18–21 change  in  the  level  of  non-specific
airways responsiveness,14,20,21 and reduction in alveo-
lar-capillary diffusion.22 Compared with asthmatics, in
normal subjects a higher dose of pure endotoxin is
required to produce bronchoconstriction.14,15,18,19,23
Although the endotoxin response is reproducible in a
given  subject,19 there  is  a  large  between-subjects
variability14,18,19,20 at  least  partially  related  to  the
airways inflammatory status24 and to the level of non-
specific airways responsiveness.25
Local and  systemic  inflammatory  responses have
been measured after endotoxin inhalation in normal
and asthmatic subjects. Significant blood leukocytosis
and neutrophilia were observed 4–8h after inhalation
of  endotoxin  both  in  normal14–16,18,22,26 and  asth-
matic subjects.21,27 This neutrophilia was not related
with the change in lung function.21,27 In vitro, small
amounts  of  endotoxin  (<  1ng/ml)  activate  human
airways macrophages, releasing several pro-inflamma-
tory  cytokines  (tumour  necrosis  factor-a (TNF-a),
interleukin (IL)-1, IL-6) and metabolites of arachidonic
acid. The  presence  of  LPS-binding  protein  and  the
soluble  fraction  of  CD14  receptor  (sCD14)  in  the
airways24 may increase the macrophage activation by
endotoxin.24,28 Six  hours  after  an  inhalation  of
endotoxin-contaminated dust, high concentrations of
IL-1, IL-1 RA, IL-6, IL-8 and TNF-a and their specific
mRNAs  were  measured  in  the  bronchoalveolar lav-
age.29 These cytokines are potential activators of the
hepatic acute-phase protein response, consistent with
the rise in the blood concentration of the C-reactive
protein  (CRP)  24h  after  endotoxin  inhala-
tion.13,17,21,26 We speculate that cytokines produced
into  the  airways  are  released  in  the  blood  and
stimulate the hepatocytes.
Airway  inflammation  characterized by  neutrophil
recruitment  in  broncho  alveolar  lavage  (BAL)  was
observed after bronchial challenge  with endotoxin-
contaminated  dusts  like  allergen  extracts,30 grain
dust29 and swine dust,17 while in normal subjects 100
mg  of  inhaled  pure  endotoxin  induced  a  100-fold
increase  in  neutrophils  from  BAL.31 A  significant
increase  in  neutrophils  measured  in  the  induced
sputum  occurred after 515,32 to 60mg33 endotoxin.
The  sputum  concentrations  in  myeloperoxidase
(MPO)  (from  neutrophils),  eosinophil  cationic  pro-
tein  (ECP)  (from  eosinophils)  and TNF-a rose  sig-
nificantly 6h after endotoxin.15
There  are  some  published  data  suggesting  that
environmental endotoxin could be a synergic factor
on  the  amplitude  of  immunoglobulin  E-mediated
response. On one hand, in allergic mild asthmatics,
an  exposure  to  air  containing  low  levels  of  endo-
toxin (250ng/m3) for 4h before bronchial challenge
with  allergen  increases significantly  both  bronchial
reactivity and antigen-induced airway eosinophilia.34
The airways cellular inflammation to inhaled allergen
is  modified  by  endotoxin  contamination  of  the
allergen extract. Indeed, while detoxified pure aller-
gen  extract  results  in  bronchial  eosinophil  recruit-
ment,  endotoxin  contamination  (1ng/ml)  causes
neutrophilia.30 On  the  other  hand,  inhalation  of
allergen  in  sensitized  subjects  leads  to  airways
plasma exsudation including extravasation of sCD14
and  lipopolysaccharide-binding  protein  (LBP).24
These proteins may enhance the capacity of inhaled
endotoxin to activate an inflammatory cascade that
may  amplify  the  inflammatory  response  to  inhaled
antigen  in  some  asthmatics,  as  was  suggested  by
several field studies.9,10,35 In the home environment,
the  amount  of  endotoxin  in  house  dust  has  been
related to the severity of asthma both in  atopic9,10
and  non-atopic  subjects.35 In  dust-mite-sensitized
subjects, the level of exposure to mite allergen was
higher  in  subjects  with  asthma than in  those with
rhinitis,  while the severity of the asthmatic disease
was significantly associated with a low forced expira-
tory  volume  in  1sec  (FEV1)  and  FEV1/forced  vital
capacity,  and  the  daily  need  for  oral  and  topical
corticosteroid,  as  well  as  with  the  asthma  score.9
More  recently,  Douwes  et  al.36 did  not  find  an
association between  endotoxin  exposure  and  peak
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children defined by asthma symptoms. However, the
daily PEF variability was very low (6.4%), suggesting
asthma  was  intermittent  or  doubtful.  Therefore,
endotoxin  should  be  considered  as  an  enhancing
rather than inducing factor in asthma.
We  recently  challenged  15  normal  subjects  with
inhaled  endotoxin  (0.5,  5,  50mg).18 Subjects  who
developed significant  increase in  body temperature
had a larger  increase in  the systemic inflammatory
response  (blood  neutrophilia  and  blood  concentra-
tions of CRP and LBP), while subjects who developed
a significant increase in airways responsiveness had
an increase in the sputum concentration of ECP. The
amplitude of the systemic response and decrease in
FEV1 were inversely associated with the atopic status,
suggesting a link between atopy and LPS responsive-
ness. This observation reinforces the hypothesis for a
mechanism linking the macrophage susceptibility to
LPS  stimulation  with  the  increase  in  macrophage
production of cytokines that inhibits the T helper cell
(Th)-2  response  and,  consequently,  the  risk  to
become atopic. Environmental exposure to LPS and
other  bacterial  wall  products,  present  in  house
dust9–12,35,36 and/or from the intestinal tract,37 could
be  a  necessary  step  for  maturation  the  immune
system and the development of a Th1-like response
through the presentation of antigen in  conjunction
with  IL-12.38–40 In  mice,  endotoxin  sensitivity  is
genetically determined, involving mutation in the Toll-
like receptor-4 (TLR4) gene,41 a co-receptor essential
for the LPS signalling. In human, recent data suggest
that polymorphisms in the genes encoding the TLR442
or  the  LPS  receptor  CD1443 may  be  related  to
symptoms and diseases.
exposure  to  endotoxin  in  early  life  could  be
protective  for  the  risk  of  atopy,  while  in  sympto-
matic  asthma  it  could  be  a  risk  factor of  a  severe
disease.
Finally,  available  data on  the  protective effect  of
anti-asthmatic  drugs  on  the  endotoxin-induced
response  are  quite  limited. An  acute  pre-treatment
with  sodium  cromoglycate44 or with  short or  long
acting B2-agonists completely prevents the broncho-
constriction induced by an acute exposure to LPS45
while, given in a single dose, an inhaled corticoste-
roid does not prevent the endotoxin-induced blood
inflammation.45 Studies  are  in  progress  to  evaluate
the  possible  protective effect  of  chronic  treatment
with  oral  corticosteroids  on  the  response  to
endotoxin.
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The  past  three  decades  have  seen  an  increase  in
reported  asthma  and  allergic  diseases  from  many
studies around  the world, recently described as an
epidemic.1 While many hypotheses have been devel-
oped to explain these changes, the hygiene hypoth-
esis  has  for  the  past  decade  encompassed  an
expanding  link  between  the  epidemiology  and
immunology  of both atopic sensitisation and atopic
diseases. These  associations  and  the  utility  of  the
hypothesis  have  recently  been  reviewed  by  David
Strachan,2 who  first  reported  the  associations
between  birth  order  and  hayfever,  and  articulated
the  hygiene  hypothesis  as  an explanation.3 Inverse
relationships between atopic and infectious  disease
was first raised a decade earlier by Gerrard et al. in
a  comparison  of  atopic  disease  amongst  the  Metis
(native Indian) and white communities of northern
Saskatchewan.4 The  immunological  basis  for  the
hypothesis  rests  on  the  concept of  immune  devia-
tion in early life towards T helper cell (Th)1 immune
responses induced by microbial exposure, with Th1
responses suppressing Th2  responses and  immuno-
globulin  E  (IgE)  production. The  hypothesis  there-
fore refers to IgE-mediated diseases such as hayfever
but is less applicable to asthma, where atopy plays
an important but not exclusive role.
The  relationships  between  asthma,  bronchial
hyperresponsiveness (BHR) and atopy have recently
been  examined among 20-  to 44-year-old adults,  in
five Spanish centres involved in the European Com-
munity Respiratory Health Survey. The adjusted pro-
portion of BHR attributable to atopy was 21% and the
proportion of asthma symptoms and BHR attributable
to  atopy  was  42%.5 Factors  associated  with  the
hygiene  hypothesis  such  as  birth  order  or  specific
infections  will  vary  in  their  strength  of association
with asthma depending on the proportion of asthma
attributable  to  atopy.  An  important  feature  of  any
useful  hypothesis  is  that  it  should  unify  disparate
observations. The hygiene hypothesis does this, sug-
gesting explanations for socio-economic variations in
atopic disease both  within and between countries,
and a plausible explanation of some of the long-term
upward trends in prevalence. Studies of the relation-
ship between infection or microbial exposures and
atopic  disease  also  tend  to  support  the  hygiene
hypothesis.
The influence of antibiotics on these associations
has  recently  been  studied.  Farooqi  et  al. found  a
twofold  risk  of  doctor-diagnosed  atopic  diseases
with antibiotic treatment in the first 2 years of life,
among  a  general  practice  birth  cohort.6 The
increased  risk  was  apparent  for  all  classes  of  anti-
biotics,  although  greater  for  cephalosporins  and
macrolides;  it  was  independent  of  the  underlying
condition  being  treated,  and  was  similar  for  those
with  and  without  a  history  of  maternal  atopy.
Antibiotic  exposure  was  the  strongest predictor of
atopic disease in this study.
The  other  two  studies  have  examined  antibiotic
use  among  children  in  Sweden  and  New  Zealand,
whose  families  have  some  association  with  an
anthroposophic  lifestyle.  Families  embracing  this
lifestyle,  whose  tenets  were  set  out  by  Rudolph
Steiner in the nineteenth century, tend to minimise
their  involvement  with  conventional  medical
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